低风险甲状腺微小乳头状癌:MAeSTro研究显示延迟手术与立即手术的甲状腺切除范围及并发症无显著差异
该多中心前瞻性队列研究纳入1177例低风险甲状腺微小乳头状癌患者,比较立即手术与主动监测后延迟手术的外科及临床结局。516例接受手术,延迟手术组肿瘤更大、淋巴管侵犯和多灶性比例更高,但全甲状腺切除率、术后甲状旁腺功能减退和声带麻痹无显著差异。延迟手术组中疾病进展者淋巴结转移和放射性碘治疗率更高。
要点
- 低风险PTMC延迟手术组肿瘤更大、淋巴管侵犯和多灶性比例更高。
- 两组全甲状腺切除率、术后甲状旁腺功能减退和声带麻痹无显著差异。
- 延迟手术组中疾病进展者淋巴结转移和放射性碘治疗率更高。
核心结论
- 就甲状腺切除范围和术后并发症而言,主动监测可作为低风险PTMC的替代治疗选择。
- 需长期随访评估肿瘤学结局。
研究设计与样本
- 多中心前瞻性队列研究,2016年6月至2020年1月在韩国3家三级医院纳入1177例低风险PTMC患者。
- 患者自我分配至主动监测组或立即手术组,主动监测期间出现疾病进展迹象或患者选择改变时接受手术。
主要发现
- 共516例接受手术,立即手术组384例(74.4%),延迟手术组132例(25.6%)。
- 与立即手术组相比,延迟手术组肿瘤更大(P=0.002)、淋巴管侵犯率更高(P=0.002)、多灶性比例更高(P=0.008)。
- 两组全甲状腺切除率(P=0.283)、术后甲状旁腺功能减退(P=0.184)和声带麻痹(P=0.284)无显著差异。
- 延迟手术组132例中39例(29.5%)存在疾病进展。
- 延迟手术组中疾病进展者淋巴结转移率(P=0.021)和放射性碘治疗率(P=0.025)显著高于无进展者。
临床怎么用
- 对低风险PTMC患者,主动监测可作为替代立即手术的选项,不增加甲状腺切除范围和术后并发症。
- 主动监测期间出现疾病进展或患者意愿改变时可转为延迟手术。
局限性
- 需长期随访以评估肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate surgical, and clinical outcomes in patients with low-risk papillary thyroid microcarcinoma (PTMC) according to treatment options [immediate operation (IOP) vs delayed operation after active surveillance (AS) (DOP)]. BACKGROUND: AS has been adopted as an alternative to immediate surgery in patients with low-risk PTMC. Although some patients undergo surgery during AS, there is little information on surgical, and clinical outcomes after delayed operation after AS. METHODS: A multicenter prospective cohort study including 1177 patients was conducted at 3 tertiary hospitals in Korea from June 2016 to January 2020. Patients with low-risk PTMC were enrolled. The participants were self-assigned into AS or IOP, and during AS, the patients underwent surgery if there were signs of disease progression or if the patient's choice changed. RESULTS: A total of 516 patients underwent operation; 384 (74.4%) in the IOP group and 132 (25.6%) in the DOP group. Compared with the IOP group, the DOP group was significantly associated with a larger tumor size ( P =0.002), higher rates of lymphatic invasion ( P =0.002), and multifocality ( P =0.008). However, the rates of total thyroidectomy, postoperative hypoparathyroidism and vocal cord palsy did not differ significantly between the groups ( P = 0.283, P =0.184, and P =0.284, respectively). Of the 132 patients in the DOP group, disease progression was present in 39 (29.5%) patients. The DOP group with disease progression had a significantly higher rate of lymph node metastasis ( P =0.021) and radioiodine therapy ( P =0.025) than the DOP group without disease progression. CONCLUSIONS: These results suggest that AS might be considered an alternative treatment option for patients with low-risk PTMC regarding the extent of thyroidectomy and postoperative complications in the DOP group. To assess oncologic outcomes, long-term follow-up will be needed. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02938702.
引用
- Hwang H, Choi JY, Yu HW, et al. Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study. Ann Surg. 2023. PMID: 36912439. doi:10.1097/SLA.0000000000005841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。